文献速递冠心病

微血管阻力储备对心肌梗死患者PCI术后的预后价值

Prognostic Value of Microvascular Resistance Reserve After Percutaneous Coronary Intervention in Patients With Myocardial Infarction.
PubMed 文献 · J Am Coll Cardiol · 2024-05-03

本研究基于6个队列的个体患者数据汇总分析,纳入直接PCI术后测量IMR的STEMI患者1265例,其中446例可同时计算MRR和IMR。中位随访3.1年,低MRR(≤1.25)组全因死亡或心衰住院复合终点发生率为27.3%,高MRR组为5.9%(HR 4.16,95%CI 2.31-7.50,P<0.001),MRR和IMR均为独立预测因子。

要点

  • 直接PCI术后MRR是STEMI患者长期全因死亡或心衰住院的独立预测因子
  • MRR预测复合终点的最佳截断值为1.25
  • MRR与IMR均可独立预测复合终点,MRR与CMR参数进行了比较

核心结论

  • 直接PCI术后测量的MRR是长期随访期间全因死亡或心衰住院复合终点的独立预测因子。

研究设计与样本

  • 研究为6个队列个体患者数据的汇总分析,纳入直接PCI术后测量IMR的STEMI患者1265例,其中446例可同时计算MRR和IMR。

主要发现

  • 中位随访3.1年(Q1-Q3:1.5-6.1年),低MRR(≤1.25)组复合终点发生率为27.3%,高MRR(>1.25)组为5.9%(HR 4.16,95%CI 2.31-7.50,P<0.001)。
  • MRR预测该STEMI人群复合终点的最佳截断值为1.25。
  • IMR和MRR均为全因死亡或心衰住院复合终点的独立预测因子。

关键数值与推荐

  • MRR预测复合终点的最佳截断值为1.25。
  • 低MRR(≤1.25)组复合终点发生率27.3%,高MRR(>1.25)组5.9%,HR 4.16(95%CI 2.31-7.50,P<0.001)。

临床怎么用

  • 直接PCI术后可计算MRR以评估微循环血管扩张能力,MRR≤1.25提示长期全因死亡或心衰住院风险较高。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The microvascular resistance reserve (MRR) has recently been introduced as a novel index to assess the vasodilatory capacity of the microcirculation, independent of epicardial disease. The prognostic value of MRR in ST-segment elevation myocardial infarction (STEMI) is unknown. OBJECTIVES: The aim of this analysis was to investigate the prognostic value of MRR in patients with STEMI and to compare MRR with cardiovascular magnetic resonance imaging parameters. METHODS: From a pooled analysis of individual patient data from 6 cohorts that measured the index of microcirculatory resistance (IMR) directly after primary percutaneous coronary intervention in patients with STEMI (n = 1,265), a subgroup analysis was performed in patients in whom both MRR and IMR were available. The primary endpoint was the composite of all-cause mortality or hospitalization for heart failure. RESULTS: Both MRR and IMR could be calculated in 446 patients. The optimal cutoff of MRR to predict the primary endpoint in this STEMI population was 1.25. During a median follow-up of 3.1 years (Q1-Q3: 1.5-6.1 years), the composite of all-cause mortality or hospitalization for heart failure occurred in 27.3% and 5.9% of patients (HR: 4.16; 95% CI: 2.31-7.50; P < 0.001) in the low MRR (≤1.25) and high MRR (>1.25) groups, respectively. Both IMR and MRR were independent predictors of the composite of all-cause mortality or hospitalization for heart failure. CONCLUSIONS: MRR measured directly after primary percutaneous coronary intervention was an independent predictor of the composite of all-cause mortality or hospitalization for heart failure during long-term follow-up.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Eerdekens, El Farissi, De Maria, et al. Prognostic Value of Microvascular Resistance Reserve After Percutaneous Coronary Intervention in Patients With Myocardial Infarction. J Am Coll Cardiol. 2024. PMID: 38752897. doi:10.1016/j.jacc.2024.02.052

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。